Trials Within Cohorts: 10667 Clinical Trials, Page 20 of 1067

Hide Studies Not Open or Pending

198

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Subjects With Malignant Solid Tumors

Condition(s):Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s); Expansion Part: Prostate Cancer; Expansion Part: Esophageal Cancer; Expansion Part: Triple Negative Breast Cancer (TNBC); Expansion Part: Squamous Cell Carcinoma of Head and Neck (SCCHN); Expansion Part: Non-small Cell Lung Cancer (NSCLC); Expansion Part: Bladder Cancer; Expansion Part: Uterine CancerLast Updated:December 14, 2020Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.